French biotech company Ipsen to buy Kartos Therapeutics for $450 million

This is a summary. Read the complete story at Investing.com below.

Related Stories

stocksabout 5 hours ago

These 3 factors "remain significant risks" to stock market valuations: analyst

Investing.com

stocksabout 6 hours ago

China Rare Earth Group in talks to buy MP Materials shareholder Shenghe Resources, sources say

Investing.com

stocksabout 6 hours ago

Billionaires abound in California. Why not tax their wealth?

Investing.com